MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 162 filers reported holding MOMENTA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $9,886,000 | +67.2% | 188,380 | +6.0% | 0.02% | +60.0% |
| Q2 2020 | $5,914,000 | +26.1% | 177,754 | +3.1% | 0.01% | 0.0% |
| Q1 2020 | $4,690,000 | +58.0% | 172,422 | +14.6% | 0.01% | +100.0% |
| Q4 2019 | $2,969,000 | +49.0% | 150,495 | -2.2% | 0.01% | +25.0% |
| Q3 2019 | $1,993,000 | +5.5% | 153,807 | +1.4% | 0.00% | 0.0% |
| Q2 2019 | $1,889,000 | -12.8% | 151,701 | +1.7% | 0.00% | 0.0% |
| Q1 2019 | $2,167,000 | +61.2% | 149,108 | +22.5% | 0.00% | +33.3% |
| Q4 2018 | $1,344,000 | -56.5% | 121,724 | +3.7% | 0.00% | -50.0% |
| Q3 2018 | $3,088,000 | +28.6% | 117,426 | -0.0% | 0.01% | +20.0% |
| Q2 2018 | $2,401,000 | +14.9% | 117,432 | +2.0% | 0.01% | +25.0% |
| Q1 2018 | $2,090,000 | +25.7% | 115,142 | -3.4% | 0.00% | +33.3% |
| Q4 2017 | $1,663,000 | -23.5% | 119,178 | +1.5% | 0.00% | -40.0% |
| Q3 2017 | $2,173,000 | -1.1% | 117,464 | -9.7% | 0.01% | 0.0% |
| Q2 2017 | $2,198,000 | +28.7% | 130,075 | +1.6% | 0.01% | +66.7% |
| Q1 2017 | $1,708,000 | -15.2% | 127,976 | -4.4% | 0.00% | -25.0% |
| Q4 2016 | $2,015,000 | +25.3% | 133,876 | -2.7% | 0.00% | +33.3% |
| Q3 2016 | $1,608,000 | +9.2% | 137,576 | +1.0% | 0.00% | 0.0% |
| Q2 2016 | $1,472,000 | +23.1% | 136,276 | +5.3% | 0.00% | 0.0% |
| Q1 2016 | $1,196,000 | -28.8% | 129,385 | +14.3% | 0.00% | -25.0% |
| Q4 2015 | $1,679,000 | -8.2% | 113,170 | +1.6% | 0.00% | -20.0% |
| Q3 2015 | $1,828,000 | -28.2% | 111,369 | -0.2% | 0.01% | -16.7% |
| Q2 2015 | $2,545,000 | +79.6% | 111,569 | +19.7% | 0.01% | +100.0% |
| Q1 2015 | $1,417,000 | +32.1% | 93,224 | +4.6% | 0.00% | 0.0% |
| Q4 2014 | $1,073,000 | +6.7% | 89,124 | +0.4% | 0.00% | +50.0% |
| Q3 2014 | $1,006,000 | -5.1% | 88,745 | +1.1% | 0.00% | -33.3% |
| Q2 2014 | $1,060,000 | +6.2% | 87,742 | +2.5% | 0.00% | 0.0% |
| Q1 2014 | $998,000 | -33.9% | 85,642 | +0.4% | 0.00% | -25.0% |
| Q4 2013 | $1,509,000 | +23.5% | 85,342 | +0.5% | 0.00% | 0.0% |
| Q3 2013 | $1,222,000 | -1.4% | 84,942 | +3.2% | 0.00% | 0.0% |
| Q2 2013 | $1,239,000 | +14.1% | 82,277 | +1.1% | 0.00% | 0.0% |
| Q1 2013 | $1,086,000 | – | 81,408 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 450,000 | $7,605,000 | 3.18% |
| ARMISTICE CAPITAL, LLC | 820,000 | $13,858,000 | 1.77% |
| Marcus Capital, LLC | 104,000 | $1,758,000 | 1.50% |
| SECTOR GAMMA AS | 605,545 | $10,234,000 | 1.49% |
| Palo Alto Investors LP | 1,787,576 | $30,210,000 | 1.41% |
| SECTORAL ASSET MANAGEMENT INC | 299,400 | $5,060,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 433,060 | $7,318,000 | 0.53% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 1,232,929 | $20,837,000 | 0.51% |
| Orbimed Advisors | 2,109,068 | $35,643,000 | 0.37% |
| TFS CAPITAL LLC | 52,290 | $884,000 | 0.35% |